A PricewaterhouseCoopers MoneyTree report found first-time investments in medical device and biotech firms were at their lowest level in 15 years in 2011, according to a Star Tribune report.
The report found the number of deals last year fell from 188 in 2010 to 153 in 2011. Due to the uncertain regulatory environment, investors are more willing to invest in mature companies or companies with devices close to being on the market, the report said.
Related Articles on Medical Devices:
Breast Implant Recall Raises Questions About CE Mark Approval Process
FDA Clears Curos Disinfecting Port Protector
Feds Drop Charges Against Former Stryker Sales Manager
The report found the number of deals last year fell from 188 in 2010 to 153 in 2011. Due to the uncertain regulatory environment, investors are more willing to invest in mature companies or companies with devices close to being on the market, the report said.
Related Articles on Medical Devices:
Breast Implant Recall Raises Questions About CE Mark Approval Process
FDA Clears Curos Disinfecting Port Protector
Feds Drop Charges Against Former Stryker Sales Manager